Literature DB >> 20057425

Kidney complications: why don't statins always work?

S Ananth Karumanchi1, Ravi Thadhani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20057425     DOI： 10.1038/nm0110-38

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  16 in total

1.  Heart attacks: gone with the century?

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728

2.  Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial.

Authors:  M Boaz; S Smetana; T Weinstein; Z Matas; U Gafter; A Iaina; A Knecht; Y Weissgarten; D Brunner; M Fainaru; M S Green
Journal:  Lancet       Date:  2000-10-07       Impact factor: 79.321

3.  Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy.

Authors:  David J Kennedy; Sandeep Vetteth; Sankaridrug M Periyasamy; Mohamed Kanj; Larisa Fedorova; Samer Khouri; M Bashar Kahaleh; Zijian Xie; Deepak Malhotra; Nikolai I Kolodkin; Edward G Lakatta; Olga V Fedorova; Alexei Y Bagrov; Joseph I Shapiro
Journal:  Hypertension       Date:  2006-01-30       Impact factor: 10.190

4.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Authors:  Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

5.  The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial.

Authors:  Martin Tepel; Markus van der Giet; Mario Statz; Joachim Jankowski; Walter Zidek
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

6.  Protein carbamylation links inflammation, smoking, uremia and atherogenesis.

Authors:  Zeneng Wang; Stephen J Nicholls; E Rene Rodriguez; Outi Kummu; Sohvi Hörkkö; John Barnard; Wanda F Reynolds; Eric J Topol; Joseph A DiDonato; Stanley L Hazen
Journal:  Nat Med       Date:  2007-09-09       Impact factor: 53.440

7.  Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition.

Authors:  Yongmei Liu; Josef Coresh; Joseph A Eustace; J Craig Longenecker; Bernard Jaar; Nancy E Fink; Russell P Tracy; Neil R Powe; Michael J Klag
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

8.  Low-dose growth hormone is cardioprotective in uremia.

Authors:  Ralph Rabkin; Ibrahim Awwad; Yu Chen; Euan A Ashley; Difei Sun; Sumita Sood; William Clusin; Paul Heidenreich; Grzegorz Piecha; Marie-Luise Gross
Journal:  J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 10.121

Review 9.  Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?

Authors:  Peter Stenvinkel; Juan Jesús Carrero; Jonas Axelsson; Bengt Lindholm; Olof Heimbürger; Ziad Massy
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-09       Impact factor: 8.237

Review 10.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690
View more
  5 in total

1.  Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study.

Authors:  Justin T Saunders; Vijay Nambi; James A de Lemos; Lloyd E Chambless; Salim S Virani; Eric Boerwinkle; Ron C Hoogeveen; Xiaoxi Liu; Brad C Astor; Thomas H Mosley; Aaron R Folsom; Gerardo Heiss; Josef Coresh; Christie M Ballantyne
Journal:  Circulation       Date:  2011-03-21       Impact factor: 29.690

2.  Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease.

Authors:  Christiane Drechsler; Sahir Kalim; Julia B Wenger; Pirianthini Suntharalingam; Tammy Hod; Ravi I Thadhani; S Ananth Karumanchi; Christoph Wanner; Anders H Berg
Journal:  Kidney Int       Date:  2015-02-11       Impact factor: 10.612

3.  Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure.

Authors:  Anders H Berg; Christiane Drechsler; Julia Wenger; Roberto Buccafusca; Tammy Hod; Sahir Kalim; Wenda Ramma; Samir M Parikh; Hanno Steen; David J Friedman; John Danziger; Christoph Wanner; Ravi Thadhani; S Ananth Karumanchi
Journal:  Sci Transl Med       Date:  2013-03-06       Impact factor: 17.956

4.  The authors reply.

Authors:  Rajiv Janardhanan; Sanjay Misra
Journal:  Kidney Int       Date:  2014-08       Impact factor: 10.612

5.  MicroRNA-142-3p improves vascular relaxation in uremia.

Authors:  Máté Kétszeri; Andrijana Kirsch; Bianca Frauscher; Foteini Moschovaki-Filippidou; Agnes A Mooslechner; Alexander H Kirsch; Corinna Schabhuettl; Ida Aringer; Katharina Artinger; Gudrun Pregartner; Robert Ekart; Silva Breznik; Radovan Hojs; Walter Goessler; Irene Schilcher; Helmut Müller; Barbara Obermayer-Pietsch; Saša Frank; Alexander R Rosenkranz; Philipp Eller; Kathrin Eller
Journal:  Atherosclerosis       Date:  2018-11-10       Impact factor: 5.162
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.